BIND Therapeutics to Present at UBS Global Healthcare Conference

[Business Wire] – BIND Therapeutics, Inc. , a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the UB more

View todays social media effects on BIND

View the latest stocks trending across Twitter. Click to view dashboard

See who BIND is hiring next, click here to view